Product Images Darifenacin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Darifenacin NDC 46708-223 by Alembic Pharmaceuticals Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

30's bottle pack - darifenacin 15mg

30's bottle pack - darifenacin 15mg

Each tablet contains 17,858 mg of darifenacin hydrobromide, providing 15 mg of darifenacin. This is an Extended-Release medication that comes in a bottle of 30 tablets. It is recommended to store this medication at 25°C (77°F) with excursions permitted for 15 to 30°C (59-86°F) and to protect from light. This medication requires a prescription and should be kept out of the reach of children. NDC number is 46708-224-30.*

30's bottle pack - darifenacin 75mg

30's bottle pack - darifenacin 75mg

Each tablet contains 8.929 mg of darifenacin hydrobromide to provide 7.5mg darifenacin. The usual dosage is one tablet a day. It should be stored at 25°C (77°F), with excursions permitted to 15-30°C (59-86°F), protected from light. This drug should be kept out of the reach of children. The NDC for this medication is 46708-223-30. This is an extended-release tablet with 30 tablets in the package. The drug is manufactured by Alembic Pharmaceuticals Limited in Panelav Village, Panchmahal, Gujarat, India. The lot number and expiration date are not available.*

Figure 1 - darifenacin figure1

Figure 1 - darifenacin figure1

This is a chart showing Darifenacin plasma concentration (in ng/mL) at different times post-dose (in hours). The chart includes data for 7.5mg and 15mg doses of Darifenacin, and separates the results for extensive metabolizers (EMs) from poor metabolizers (PMs). The chart shows the mean, as well as the standard deviation (SD) for each set of data, but there are no units provided for the y-axis.*

Figure 2a - darifenacin figurea2

Figure 2a - darifenacin figurea2

Figure 2b - darifenacin figureb2

Figure 2b - darifenacin figureb2

Figure 2c - darifenacin figurec2

Figure 2c - darifenacin figurec2

Structure - darifenacin str

Structure - darifenacin str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.